Amdocs’ (DOX) Peer Perform Rating Reiterated at Wolfe Research

Wolfe Research reaffirmed their peer perform rating on shares of Amdocs (NASDAQ:DOXFree Report) in a report released on Thursday, Marketbeat Ratings reports.

DOX has been the subject of several other research reports. Stifel Nicolaus decreased their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a report on Thursday, October 30th. Wall Street Zen downgraded Amdocs from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. Finally, Bank of America decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $97.00.

Check Out Our Latest Stock Report on DOX

Amdocs Price Performance

NASDAQ:DOX opened at $77.74 on Thursday. The stock’s fifty day moving average is $83.02 and its two-hundred day moving average is $87.27. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $8.78 billion, a P/E ratio of 15.77, a P/E/G ratio of 1.40 and a beta of 0.51. Amdocs has a 52 week low of $75.35 and a 52 week high of $95.41.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.83 EPS for the quarter, beating the consensus estimate of $1.82 by $0.01. The business had revenue of $1.15 billion during the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The business’s revenue for the quarter was down 9.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. Equities analysts expect that Amdocs will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a dividend of $0.527 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $2.11 annualized dividend and a yield of 2.7%. Amdocs’s dividend payout ratio (DPR) is currently 41.58%.

Institutional Trading of Amdocs

Hedge funds have recently modified their holdings of the company. Dakota Wealth Management acquired a new position in Amdocs during the 2nd quarter worth about $458,000. Foster & Motley Inc. lifted its stake in shares of Amdocs by 21.0% in the second quarter. Foster & Motley Inc. now owns 45,764 shares of the technology company’s stock worth $4,176,000 after acquiring an additional 7,934 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its stake in Amdocs by 15.6% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 10,555 shares of the technology company’s stock worth $963,000 after acquiring an additional 1,421 shares during the period. Acadian Asset Management LLC increased its position in Amdocs by 36.2% in the 2nd quarter. Acadian Asset Management LLC now owns 684,218 shares of the technology company’s stock valued at $62,416,000 after acquiring an additional 181,719 shares during the period. Finally, Pzena Investment Management LLC lifted its holdings in Amdocs by 2.1% in the 2nd quarter. Pzena Investment Management LLC now owns 6,551,065 shares of the technology company’s stock valued at $597,719,000 after acquiring an additional 132,463 shares during the last quarter. 92.02% of the stock is owned by hedge funds and other institutional investors.

Amdocs Company Profile

(Get Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.